Public health initiatives often emphasize the importance of vaccination alongside antiviral medications like Tamiflu to provide comprehensive protection against influenza outbreaks
Retatrutide (LY3437943), developed by Eli Lilly, is a first-in-class triple GIP/GLP-1/glucagon receptor agonist
Adjusting tirzepatide titration schedules can reduce side effects without compromising long-term efficacy
Bring it to your healthcare provider and specifically ask: "Which of these can cause weight gain, and are there weight-neutral alternatives?" The medications most likely to interfere were listed earlier: antipsychotics, certain antidepressants, corticosteroids, insulin, sulfonylureas, gabapentin, pregabalin, beta-blockers, lithium, and valproate